SANTA CRUZ BIOTECHNOLOGY, INC. DDX50 shRNA (m) Lentiviral Particles: sc-142942-V

BACKGROUND APPLICATIONS DDX50 (Probable ATP-dependent RNA DDX50, Nucleolar protein DDX50 shRNA (m) Lentiviral Particles is recommended for the inhibition of Gu2, Gu-β) is a 737 amino acid protein encoded by the human DDX50. DDX50 expression in mouse cells. DDX50 belongs to the DEAD box helicase family, DDX21/DDX50 subfamily and contains one helicase ATP-binding domain and one C-terminal helicase SUPPORT REAGENTS domain. DDX50 is a functional interaction partner of c-Jun in human cells. Control shRNA Lentiviral Particles: sc-108080. Available as 200 µl frozen The N-terminal transcription activation region of c-Jun interacts with a C-ter- viral stock containing 1.0 x 106 infectious units of virus (IFU); contains an minal domain of DDX50. This interaction is stimulated by anisomycin treat- shRNA construct encoding a scrambled sequence that will not lead to the ment in a manner that is concurrent with, but independent of, c-Jun phos- specific degradation of any known cellular mRNA. phorylation. DDX50 is also believed to be a probable ATP-dependent RNA helicase. RNA are highly conserved that utilize the ener- RT-PCR REAGENTS gy derived from NTP hydrolysis to modulate the structure of RNA. RNA heli- cases participate in all biological processes that involve RNA, including tran- Semi-quantitative RT-PCR may be performed to monitor DDX50 gene expres- scription, splicing and translation. sion knockdown using RT-PCR Primer: DDX50 (m)-PR: sc-142942-PR (20 µl). Annealing temperature for the primers should be 55-60° C and the extension REFERENCES temperature should be 68-72° C. 1. Doorbar, J., et al. 2000. The E1E4 protein of human papillomavirus type 16 BIOSAFETY associates with a putative RNA helicase through sequences in its C termi- nus. J. Virol. 74: 10081-10095. Lentiviral particles can be employed in standard Biosafety Level 2 tissue culture facilities (and should be treated with the same level of caution as 2. Bhattacharya, R., et al. 2002. Methylphosphate cap structure in small RNAs with any other potentially infectious reagent). Lentiviral particles are repli- reduces the affinity of RNAs to La protein. Gene Expr. 10: 243-253. cation-incompetent and are designed to self-inactivate after transduction 3. Valdez, B.C., et al. 2002. Expression, cellular localization, and enzymatic and integration of shRNA constructs into genomic DNA of target cells. activities of RNA helicase II/Guβ. Exp. Cell Res. 276: 249-263. RESEARCH USE 4. Westermarck, J., et al. 2002. The DEXD/H-box RNA helicase RHII/Gu is a co-factor for c-Jun-activated transcription. EMBO J. 21: 451-460. The purchase of this product conveys to the buyer the nontransferable right to use the purchased amount of the product and all replicates and derivatives 5. Regard, J.B., et al. 2004. Verge: a novel vascular early response gene. J. for research purposes conducted by the buyer in his laboratory only (whether Neurosci. 24: 4092-4103. the buyer is an academic or for-profit entity). The buyer cannot sell or other- wise transfer (a) this product (b) its components or (c) materials made using CHROMOSOMAL LOCATION this product or its components to a third party, or otherwise use this product Genetic locus: Ddx50 (mouse) mapping to 10 B4. or its components or materials made using this product or its components for Commercial Purposes. PRODUCT DDX50 shRNA (m) Lentiviral Particles are concentrated, transduction-ready viral particles containing a target-specific construct that encodes a 19-25 nt (plus hairpin) shRNA designed to knock down . Each vial con- tains 200 µl frozen stock containing 1.0 x 106 infectious units of virus (IFU) in Dulbecco’s Modified Eagle’s Medium with 25 mM HEPES pH 7.3. Suitable for 10-20 transductions. Also see DDX50 siRNA (m): sc-142942 and DDX50 shRNA Plasmid (m): sc-142942-SH as alternate gene silencing products.

STORAGE Store lentiviral particles at -80º C. Stable for at least one year from the date of shipment. Once thawed, particles can be stored at 4º C for up to one week. Avoid repeated freeze thaw cycles.

PROTOCOLS See our web site at www.scbt.com for detailed protocols and support products.

Santa Cruz Biotechnology, Inc. 1.800.457.3801 831.457.3800 fax 831.457.3801 Europe +00800 4573 8000 49 6221 4503 0 www.scbt.com